Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Horse Diseases | 6 | 2023 | 56 | 1.960 |
Why?
|
Diabetes, Gestational | 15 | 2024 | 1263 | 1.340 |
Why?
|
Sarcocystosis | 3 | 2023 | 3 | 0.990 |
Why?
|
Sarcocystis | 3 | 2023 | 5 | 0.990 |
Why?
|
Placenta | 14 | 2024 | 1725 | 0.880 |
Why?
|
Glucose Intolerance | 6 | 2024 | 579 | 0.820 |
Why?
|
Pregnancy | 75 | 2024 | 30215 | 0.820 |
Why?
|
Encephalomyelitis | 2 | 2023 | 37 | 0.770 |
Why?
|
Labor, Obstetric | 5 | 2023 | 313 | 0.670 |
Why?
|
Insemination, Artificial | 5 | 2024 | 99 | 0.650 |
Why?
|
Premature Birth | 9 | 2024 | 1829 | 0.650 |
Why?
|
Delivery, Obstetric | 9 | 2024 | 945 | 0.640 |
Why?
|
Postpartum Period | 10 | 2024 | 1196 | 0.630 |
Why?
|
Anti-Mullerian Hormone | 5 | 2023 | 420 | 0.620 |
Why?
|
Cesarean Section | 8 | 2023 | 1418 | 0.590 |
Why?
|
Neospora | 1 | 2017 | 2 | 0.580 |
Why?
|
Coccidiosis | 1 | 2017 | 10 | 0.570 |
Why?
|
Ovulation Induction | 5 | 2024 | 276 | 0.550 |
Why?
|
Pregnancy Outcome | 12 | 2024 | 2968 | 0.530 |
Why?
|
Fertilization in Vitro | 6 | 2024 | 1301 | 0.530 |
Why?
|
Embryo Transfer | 5 | 2024 | 526 | 0.490 |
Why?
|
Horses | 6 | 2023 | 295 | 0.470 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 705 | 0.440 |
Why?
|
Version, Fetal | 2 | 2023 | 20 | 0.430 |
Why?
|
Breech Presentation | 2 | 2023 | 38 | 0.420 |
Why?
|
Glucose Tolerance Test | 10 | 2024 | 1180 | 0.400 |
Why?
|
Gonadotropins | 2 | 2024 | 240 | 0.380 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2021 | 391 | 0.380 |
Why?
|
Suburethral Slings | 2 | 2023 | 69 | 0.370 |
Why?
|
Pregnancy Rate | 7 | 2024 | 654 | 0.370 |
Why?
|
Labor, Induced | 3 | 2021 | 153 | 0.370 |
Why?
|
Live Birth | 5 | 2022 | 516 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2022 | 2184 | 0.340 |
Why?
|
Endometrium | 2 | 2024 | 405 | 0.330 |
Why?
|
Placenta Diseases | 2 | 2023 | 199 | 0.320 |
Why?
|
Prenatal Care | 4 | 2020 | 1157 | 0.310 |
Why?
|
Female | 94 | 2024 | 396050 | 0.300 |
Why?
|
Vaginal Diseases | 2 | 2019 | 103 | 0.300 |
Why?
|
Infertility, Female | 4 | 2024 | 763 | 0.290 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2024 | 531 | 0.290 |
Why?
|
Blood Glucose | 10 | 2024 | 6422 | 0.280 |
Why?
|
Postpartum Hemorrhage | 2 | 2021 | 275 | 0.280 |
Why?
|
Clomiphene | 2 | 2024 | 71 | 0.270 |
Why?
|
Labor Stage, Second | 2 | 2024 | 45 | 0.270 |
Why?
|
Fertility Agents, Female | 2 | 2024 | 101 | 0.270 |
Why?
|
Fetal Blood | 3 | 2023 | 1364 | 0.260 |
Why?
|
Apgar Score | 2 | 2024 | 125 | 0.260 |
Why?
|
Infertility | 2 | 2023 | 655 | 0.260 |
Why?
|
Glucose | 6 | 2023 | 4332 | 0.250 |
Why?
|
Infant, Newborn | 21 | 2024 | 26337 | 0.250 |
Why?
|
Pain, Postoperative | 4 | 2021 | 1769 | 0.240 |
Why?
|
Obstetrics | 3 | 2024 | 679 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2024 | 3987 | 0.240 |
Why?
|
Term Birth | 3 | 2021 | 140 | 0.230 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2024 | 83 | 0.230 |
Why?
|
Retrospective Studies | 35 | 2024 | 81505 | 0.230 |
Why?
|
Insurance, Health | 4 | 2021 | 2521 | 0.220 |
Why?
|
Urinary Incontinence, Stress | 2 | 2023 | 180 | 0.220 |
Why?
|
Gynecology | 2 | 2021 | 534 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.220 |
Why?
|
Oocyte Retrieval | 2 | 2021 | 162 | 0.210 |
Why?
|
Natural Language Processing | 2 | 2022 | 1198 | 0.210 |
Why?
|
Information Seeking Behavior | 1 | 2024 | 116 | 0.210 |
Why?
|
Betamethasone | 1 | 2022 | 48 | 0.200 |
Why?
|
Humans | 94 | 2024 | 765823 | 0.200 |
Why?
|
Birth Weight | 4 | 2024 | 2121 | 0.200 |
Why?
|
Burnout, Professional | 2 | 2022 | 710 | 0.200 |
Why?
|
Fetal Macrosomia | 2 | 2024 | 138 | 0.200 |
Why?
|
Medicaid | 3 | 2021 | 2832 | 0.200 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2024 | 503 | 0.200 |
Why?
|
Pregnancy Complications | 5 | 2024 | 2970 | 0.200 |
Why?
|
Hospitals | 3 | 2021 | 3887 | 0.200 |
Why?
|
Adult | 47 | 2024 | 223055 | 0.200 |
Why?
|
Toxoplasma | 1 | 2023 | 158 | 0.190 |
Why?
|
Infant, Newborn, Diseases | 3 | 2024 | 587 | 0.190 |
Why?
|
Parity | 5 | 2023 | 930 | 0.190 |
Why?
|
Erbovirus | 1 | 2021 | 1 | 0.190 |
Why?
|
Psychological Tests | 1 | 2023 | 643 | 0.190 |
Why?
|
Bodily Secretions | 1 | 2021 | 28 | 0.180 |
Why?
|
Gestational Age | 7 | 2024 | 3614 | 0.180 |
Why?
|
Pelvic Organ Prolapse | 1 | 2023 | 116 | 0.180 |
Why?
|
Abortion, Spontaneous | 3 | 2021 | 535 | 0.180 |
Why?
|
Equidae | 1 | 2020 | 10 | 0.180 |
Why?
|
Pregnancy in Diabetics | 1 | 2022 | 198 | 0.180 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.180 |
Why?
|
Anovulation | 1 | 2020 | 55 | 0.180 |
Why?
|
Fetal Resorption | 1 | 2020 | 15 | 0.180 |
Why?
|
Carcinoma, Endometrioid | 1 | 2023 | 274 | 0.180 |
Why?
|
Antibodies, Protozoan | 2 | 2023 | 250 | 0.180 |
Why?
|
Obstetric Labor Complications | 2 | 2024 | 239 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Anal Canal | 1 | 2023 | 376 | 0.170 |
Why?
|
Serum Albumin | 1 | 2023 | 674 | 0.170 |
Why?
|
Hypoglycemia | 2 | 2024 | 896 | 0.170 |
Why?
|
Asthma | 3 | 2023 | 6268 | 0.170 |
Why?
|
Picornaviridae Infections | 1 | 2021 | 97 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1353 | 0.170 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2023 | 361 | 0.160 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1024 | 0.160 |
Why?
|
Counseling | 2 | 2024 | 1551 | 0.160 |
Why?
|
Analgesia, Epidural | 1 | 2022 | 332 | 0.160 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Pelvis | 2 | 2023 | 738 | 0.160 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3210 | 0.160 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 261 | 0.160 |
Why?
|
Dystocia | 1 | 2018 | 33 | 0.160 |
Why?
|
Vulvar Diseases | 1 | 2019 | 64 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 453 | 0.150 |
Why?
|
Fecal Incontinence | 1 | 2021 | 246 | 0.150 |
Why?
|
Obstetric Labor, Premature | 1 | 2020 | 268 | 0.150 |
Why?
|
Attitude of Health Personnel | 2 | 2024 | 3925 | 0.150 |
Why?
|
Chorioamnionitis | 1 | 2019 | 154 | 0.150 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 395 | 0.140 |
Why?
|
Abruptio Placentae | 1 | 2019 | 116 | 0.140 |
Why?
|
Insurance Coverage | 2 | 2019 | 1946 | 0.140 |
Why?
|
Electronic Health Records | 4 | 2022 | 4864 | 0.140 |
Why?
|
Preconception Care | 1 | 2018 | 143 | 0.140 |
Why?
|
Dental Care | 1 | 2020 | 286 | 0.140 |
Why?
|
Acetaminophen | 1 | 2021 | 548 | 0.140 |
Why?
|
Ureter | 1 | 2020 | 364 | 0.140 |
Why?
|
Nose | 1 | 2021 | 518 | 0.140 |
Why?
|
Preimplantation Diagnosis | 1 | 2019 | 143 | 0.140 |
Why?
|
Risk Factors | 17 | 2024 | 74853 | 0.140 |
Why?
|
Medically Uninsured | 2 | 2021 | 838 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2023 | 492 | 0.140 |
Why?
|
Aorta, Abdominal | 1 | 2020 | 630 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2021 | 490 | 0.140 |
Why?
|
Staff Development | 1 | 2018 | 230 | 0.130 |
Why?
|
Dietary Carbohydrates | 1 | 2021 | 895 | 0.130 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2024 | 855 | 0.130 |
Why?
|
Cervix Uteri | 1 | 2020 | 575 | 0.130 |
Why?
|
Urology | 1 | 2021 | 384 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 374 | 0.130 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26276 | 0.130 |
Why?
|
Puerperal Disorders | 1 | 2018 | 304 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2019 | 494 | 0.120 |
Why?
|
Fever | 2 | 2021 | 1603 | 0.120 |
Why?
|
Bupivacaine | 1 | 2018 | 414 | 0.120 |
Why?
|
Celiac Disease | 1 | 2023 | 820 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1039 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 780 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 723 | 0.120 |
Why?
|
Physicians, Women | 1 | 2021 | 512 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2020 | 933 | 0.120 |
Why?
|
Liposomes | 1 | 2018 | 787 | 0.110 |
Why?
|
Cryopreservation | 1 | 2019 | 727 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2023 | 4903 | 0.110 |
Why?
|
Leiomyoma | 1 | 2019 | 644 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1510 | 0.110 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 1379 | 0.110 |
Why?
|
Embryo, Mammalian | 1 | 2019 | 1673 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5889 | 0.110 |
Why?
|
Health Services Research | 1 | 2020 | 1811 | 0.100 |
Why?
|
Qualitative Research | 1 | 2024 | 3135 | 0.100 |
Why?
|
Hysterectomy | 1 | 2018 | 865 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 830 | 0.100 |
Why?
|
Maternal Health Services | 1 | 2018 | 472 | 0.100 |
Why?
|
Analgesics, Opioid | 2 | 2019 | 3834 | 0.100 |
Why?
|
Insemination | 2 | 2022 | 18 | 0.100 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2019 | 1188 | 0.100 |
Why?
|
Self Report | 1 | 2023 | 3768 | 0.100 |
Why?
|
Cohort Studies | 10 | 2024 | 41643 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4526 | 0.100 |
Why?
|
Risk Assessment | 6 | 2024 | 24278 | 0.100 |
Why?
|
Anesthetics, Local | 1 | 2018 | 1003 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2532 | 0.090 |
Why?
|
Morbidity | 3 | 2021 | 1752 | 0.090 |
Why?
|
Logistic Models | 5 | 2024 | 13266 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 1352 | 0.090 |
Why?
|
Stillbirth | 2 | 2024 | 381 | 0.090 |
Why?
|
Postmenopause | 1 | 2019 | 2517 | 0.080 |
Why?
|
Microglia | 1 | 2018 | 1370 | 0.080 |
Why?
|
Physicians | 3 | 2024 | 4587 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.080 |
Why?
|
Amniotic Fluid | 2 | 2023 | 380 | 0.080 |
Why?
|
Prospective Studies | 9 | 2023 | 54798 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3271 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 2 | 2024 | 468 | 0.080 |
Why?
|
United States | 10 | 2024 | 72896 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2041 | 0.070 |
Why?
|
Parturition | 2 | 2023 | 453 | 0.070 |
Why?
|
Massachusetts | 4 | 2023 | 8875 | 0.070 |
Why?
|
Macrophages | 2 | 2023 | 5771 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10607 | 0.070 |
Why?
|
Primary Health Care | 1 | 2024 | 4735 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3284 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3614 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2656 | 0.070 |
Why?
|
Young Adult | 10 | 2024 | 59849 | 0.070 |
Why?
|
Steroids | 2 | 2022 | 932 | 0.070 |
Why?
|
Prevalence | 3 | 2021 | 15832 | 0.070 |
Why?
|
Body Mass Index | 2 | 2022 | 13041 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7476 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2956 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3640 | 0.060 |
Why?
|
HIV Infections | 2 | 2023 | 17530 | 0.060 |
Why?
|
Pregnant Women | 2 | 2021 | 575 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2023 | 15794 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2428 | 0.060 |
Why?
|
Animals | 7 | 2023 | 168730 | 0.060 |
Why?
|
Cardiotocography | 1 | 2024 | 33 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7073 | 0.060 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2024 | 30 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4303 | 0.060 |
Why?
|
Trophoblasts | 1 | 2024 | 223 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4860 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13466 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 239 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
Postnatal Care | 1 | 2024 | 274 | 0.050 |
Why?
|
Male | 12 | 2024 | 363740 | 0.050 |
Why?
|
New England | 1 | 2024 | 1059 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2019 | 3099 | 0.050 |
Why?
|
Blastocyst | 1 | 2024 | 432 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2023 | 457 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2024 | 441 | 0.040 |
Why?
|
Infant | 4 | 2023 | 36375 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 251 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 223016 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 404 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 22227 | 0.040 |
Why?
|
Cervical Length Measurement | 1 | 2020 | 47 | 0.040 |
Why?
|
Pain Measurement | 2 | 2021 | 3559 | 0.040 |
Why?
|
Triazines | 1 | 2021 | 306 | 0.040 |
Why?
|
Fentanyl | 1 | 2022 | 451 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20131 | 0.040 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2024 | 595 | 0.040 |
Why?
|
Meconium | 1 | 2019 | 47 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10803 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2021 | 731 | 0.040 |
Why?
|
Pregnancy, Multiple | 1 | 2019 | 216 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 303 | 0.040 |
Why?
|
Uterine Inertia | 1 | 2018 | 29 | 0.040 |
Why?
|
Uganda | 1 | 2023 | 1353 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 384 | 0.040 |
Why?
|
Fetal Development | 1 | 2024 | 777 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3425 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 587 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2021 | 315 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2022 | 548 | 0.040 |
Why?
|
Fertilization | 1 | 2018 | 197 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2018 | 121 | 0.040 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2018 | 212 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1125 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.040 |
Why?
|
Insulin | 2 | 2023 | 6601 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1260 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 508 | 0.030 |
Why?
|
Placebos | 1 | 2021 | 1659 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 453 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 737 | 0.030 |
Why?
|
Cough | 1 | 2021 | 597 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1639 | 0.030 |
Why?
|
Botswana | 1 | 2020 | 1057 | 0.030 |
Why?
|
Ovary | 1 | 2021 | 957 | 0.030 |
Why?
|
Critical Pathways | 1 | 2020 | 475 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 983 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3617 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1527 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 2019 | 416 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 832 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1884 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10570 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2655 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1587 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1538 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 88794 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1878 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 893 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21501 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1270 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6272 | 0.030 |
Why?
|
Mothers | 1 | 2024 | 2207 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8698 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2415 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1881 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2353 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15881 | 0.030 |
Why?
|
HIV | 1 | 2020 | 1585 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3316 | 0.020 |
Why?
|
RNA, Viral | 1 | 2020 | 2863 | 0.020 |
Why?
|
Feces | 1 | 2019 | 1503 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1296 | 0.020 |
Why?
|
Focus Groups | 1 | 2018 | 1459 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2444 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2023 | 59506 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2780 | 0.020 |
Why?
|
Educational Measurement | 1 | 2018 | 1258 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5873 | 0.020 |
Why?
|
Educational Status | 1 | 2018 | 2511 | 0.020 |
Why?
|
Menopause | 1 | 2019 | 1661 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2213 | 0.020 |
Why?
|
Preoperative Care | 1 | 2020 | 2244 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4058 | 0.020 |
Why?
|
Child | 3 | 2023 | 80509 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8725 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6508 | 0.020 |
Why?
|
Child, Preschool | 2 | 2023 | 42478 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2082 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4056 | 0.020 |
Why?
|
Nurses | 1 | 2019 | 2505 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9355 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6320 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1805 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29915 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2339 | 0.020 |
Why?
|
Terminal Care | 1 | 2020 | 1769 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11205 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7237 | 0.020 |
Why?
|
Aged | 4 | 2023 | 171178 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9520 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4350 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12421 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2714 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12520 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9653 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9336 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12966 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8320 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3780 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3955 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3229 | 0.010 |
Why?
|
Depression | 1 | 2023 | 8224 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14745 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3845 | 0.010 |
Why?
|
Diet | 1 | 2021 | 8085 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65223 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13078 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14062 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40109 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20680 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36542 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81788 | 0.010 |
Why?
|